[Third-line CPT-11 chemotherapy for gastric cancer cases of non-curative gastrectomy or recurrence].

Hideki Kawamura, Ryoichi Yokota, Hiroshi Watarai, Kentaro Yokota, Toshiro Tanioka, Yoshihiko Tsunoda, Hiroyuki Masuko, Kōichi Tanaka, Hideki Yamagami, Tsunetake Hata, Kuniaki Okada, Hiroyuki Ishizu, Yukifumi KondoPubMed 2010

Abstract

The group administered 3rd-line chemotherapy survived the longest. It is probably correct to administer 3rd-line chemotherapy, if the patient maintains a good performance status.
BibTeX
@inproceedings{kawamura2010third,
  author = {Hideki Kawamura and Ryoichi Yokota and Hiroshi Watarai and Kentaro Yokota and Toshiro Tanioka and Yoshihiko Tsunoda and Hiroyuki Masuko and Kōichi Tanaka and Hideki Yamagami and Tsunetake Hata and Kuniaki Okada and Hiroyuki Ishizu and Yukifumi Kondo},
  title = {{[Third-line CPT-11 chemotherapy for gastric cancer cases of non-curative gastrectomy or recurrence].}},
  booktitle = {PubMed},
  year = {2010},
}

Loading related content...

Figure